Patents by Inventor Bryan Knuckley

Bryan Knuckley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12358867
    Abstract: Novel peptoid compounds, compositions and methods of using the compounds and compositions to inhibit protein arginine methyltransferase (PRMT) and induce apoptosis in cancer cells are presented.
    Type: Grant
    Filed: April 23, 2024
    Date of Patent: July 15, 2025
    Assignee: University of North Florida Board of Trustees
    Inventors: Bryan Knuckley, Corey P. Causey, Fatima Khwaja Rehman
  • Patent number: 11993556
    Abstract: Novel peptoid compounds, compositions and methods of using the compounds and compositions to inhibit protein arginine methyltransferase (PRMT) and induce apoptosis in cancer cells are presented.
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: May 28, 2024
    Assignee: University of North Florida Board of Trustees
    Inventors: Bryan Knuckley, Corey P. Causey, Fatima Khwaja Rehman
  • Patent number: 8007996
    Abstract: In accordance with one embodiment of the present disclosure, a method to identify a protein arginine deiminase 4 inhibitor is disclosed. The method includes performing a competitive assay in which a potential inhibitor compound competes with rhodamine-conjugated fluoroamidine to bind to protein arginine deiminase 4. Fluorescence is measured to determine an estimate of the amount of fluorescent protein arginine deiminase 4 that is present in the assay.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: August 30, 2011
    Assignee: University of South Carolina
    Inventors: Paul R. Thompson, Bryan Knuckley
  • Publication number: 20090162877
    Abstract: In accordance with one embodiment of the present disclosure, a method to identify a protein arginine deiminase 4 inhibitor is disclosed. The method includes performing a competitive assay in which a potential inhibitor compound competes with rhodamine-conjugated fluoroamidine to bind to protein arginine deiminase 4. Fluorescence is measured to determine an estimate of the amount of fluorescent protein arginine deiminase 4 that is present in the assay.
    Type: Application
    Filed: October 31, 2008
    Publication date: June 25, 2009
    Applicant: University of South Carolina
    Inventors: Paul Ryan Thompson, Bryan Knuckley